Susceptibility of multi-resistant Streptococcus pneumoniae to ciprofloxacin, ofloxacin and levofloxacin

被引：11
|
作者：
Fuchs, PC
Barry, AL
Brown, SD
机构：
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1997年 / 39卷 / 05期
关键词：
D O I：
10.1093/jac/39.5.671
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：671 / 672
页数：2
相关论文
共 50 条
  • [31] Nosocomial outbreak of multi-resistant Streptococcus pneumoniae serotype 15A in a centre for chronic pulmonary diseases
    Bastiaens, Guido J. H.
    Cremers, Amelieke J. H.
    Coolen, Jordy P. M.
    Nillesen, Mayke T.
    Boeree, Martin J.
    Hopman, Joost
    Wertheim, Heiman F. L.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2018, 7
  • [32] Activities of newer fluoroquinolones against ciprofloxacin resistant Streptococcus pneumoniae
    Coyle, EA
    Kaatz, GW
    Rybak, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1654 - 1659
  • [33] Gatifloxacin and moxifloxacin: An in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates
    Kowalski, RP
    Dhaliwal, DK
    Karenchak, LM
    Romanowski, EG
    Mah, FS
    Ritterband, DC
    Gordon, YJ
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (03) : 500 - 505
  • [34] Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection
    Lacy, MK
    Lu, W
    Xu, XW
    Tessier, PR
    Nicolau, DP
    Quintiliani, R
    Nightingale, CH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (03) : 672 - 677
  • [35] Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia
    Onyeji, CO
    Bui, KQ
    Owens, RC
    Nicolau, DP
    Quintiliani, R
    Nightingale, CH
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 12 (02) : 107 - 114
  • [36] Synergistic activity and immunomodulatory potential of levofloxacin and Synoeca-MP peptide against multi-resistant strains of Klebsiella pneumoniae
    de Farias, Jade Ormondes
    Resende Ferreira, Arthur Correa
    Cardoso Kostopoulos, Alessandra Godoi
    Berto Rezende, Taia Maria
    Dias, Simoni Campos
    MICROBIAL PATHOGENESIS, 2022, 163
  • [37] Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America
    Karlowsky, JA
    Nealy, L
    Sahm, DF
    Thornsberry, C
    Jones, ME
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (07) : 2748 - 2749
  • [38] Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model
    Hershberger, E
    Rybak, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 598 - 601
  • [39] Clinical levofloxacin-resistant Streptococcus pneumoniae isolates in North Africa
    Ktari, Sonia
    Ben Ayed, Nour El Houda
    Jmal, Ikram
    Mnif, Basma
    Mezghani, Sonda
    Rhimi, Faouzia
    Hammami, Adnene
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 12 : 181 - 182
  • [40] Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill
    Visalli, MA
    Jacobs, MR
    Appelbaum, PC
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 28 (03) : 131 - 137
12345